Alpha Crest Capital Management LLC Abiomed Inc Transaction History

Alpha Crest Capital Management LLC

$0
Q4 2022

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $157,376 - $195,647	-649 Reduced 8.9%	6,642 $1.63 Million
Q2 2022 Aug 11, 2022	BUY	$224.73 - $338.64 $1.05 Million - $1.59 Million	4,693 Added 180.64%	7,291 $1.81 Million
Q1 2022 May 12, 2022	SELL	$277.25 - $366.29 $2.25 Million - $2.97 Million	-8,120 Reduced 75.76%	2,598 $861,000
Q4 2021 Feb 09, 2022	BUY	$300.63 - $371.35 $2.19 Million - $2.7 Million	7,282 Added 211.93%	10,718 $3.85 Million
Q3 2021 Nov 10, 2021	SELL	$310.19 - $376.2 $257,147 - $311,869	-829 Reduced 19.44%	3,436 $1.12 Million
Q2 2021 Aug 12, 2021	SELL	$262.71 - $351.17 $315,514 - $421,755	-1,201 Reduced 21.97%	4,265 $1.33 Million
Q1 2021 May 13, 2021	BUY	$285.92 - $355.13 $1.2 Million - $1.49 Million	4,189 Added 328.03%	5,466 $1.74 Million
Q4 2020 Feb 12, 2021	SELL	$251.88 - $324.2 $130,473 - $167,935	-518 Reduced 28.86%	1,277 $414,000
Q3 2020 Nov 12, 2020	SELL	$255.22 - $317.0 $64,315 - $79,884	-252 Reduced 12.31%	1,795 $497,000
Q2 2020 Aug 12, 2020	SELL	$141.4 - $257.09 $371,882 - $676,146	-2,630 Reduced 56.23%	2,047 $494,000
Q1 2020 May 13, 2020	SELL	$130.51 - $196.01 $398,316 - $598,222	-3,052 Reduced 39.49%	4,677 $679,000
Q4 2019 Feb 12, 2020	SELL	$159.31 - $223.54 $39,190 - $54,990	-246 Reduced 3.08%	7,729 $1.32 Million
Q3 2019 Nov 12, 2019	BUY	$175.89 - $279.23 $706,901 - $1.12 Million	4,019 Added 101.59%	7,975 $1.42 Million
Q2 2019 Aug 12, 2019	SELL	$250.96 - $284.94 $381,208 - $432,823	-1,519 Reduced 27.74%	3,956 $1.03 Million
Q1 2019 May 10, 2019	BUY	$276.39 - $362.25 $1.51 Million - $1.98 Million	5,475 New	5,475 $1.56 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Account